Loading…
CIK 0001969764 • 6 13F filings • May 15, 2025 – Aug 13, 2026
Import this data to Google Sheets with:
=jivedata("propel-bio-management-llc","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| AARDVARK THERAPEUTICS INC | COM | $609K | 0.5% | 46,408 SH | New |
| ABEONA THERAPEUTICS INC | COM NEW | $4.4M | 3.7%Prev: 5.1% | 830,780 SH | Decreased-143,242 SH |
| ACHIEVE LIFE SCIENCES INC | COM | $18.8M | 16.1%Prev: 11.9% | 3,786,425 SH | Increased |
| ATHIRA PHARMA INC | COM | $1.1M | 1.0%Prev: 0.6% | 149,279 SH | Increased |
| CELLDEX THERAPEUTICS INC | COM NEW | $4.2M | 3.6%Prev: 4.0% | 154,300 SH | Increased-700 SH |
| COMPASS PATHWAYS PLC | SPONSORED ADS | $5.9M | 5.1%Prev: 2.9% | 861,778 SH | Increased+351,778 SH |
| DELCATH SYSTEMS INC | COM NEW | $4.4M | 3.8%Prev: 4.7% | 438,509 SH | Decreased |
| INVENTIVA SA - ADR | ADS | $4.7M | 4.0% | 1,000,000 SH | New |
| KALARIS THERAPEUTICS INC | COM | $355K | 0.3% | 42,053 SH | New |
| KYVERNA THERAPEUTICS INC | COM | $6.3M | 5.4% | 666,666 SH | New |
| LENZ THERAPEUTICS INC | COM | $945K | 0.8% | 59,085 SH | New |
| MILESTONE PHARMACEUTICALS | COM | $8.3M | 7.1%Prev: 10.3% | 4,118,321 SH | Decreased-1,006,569 SH |
| NEKTAR THERAPEUTICS | COM NEW | $3.5M | 3.0%Prev: 2.8% | 82,822 SH | Increased+33,822 SH |
| OCULIS HOLDING AG | ORDINARY SHARES | $3.5M | 2.9% | 172,839 SH | New |
| PHATHOM PHARMACEUTICALS INC | COM | $12.3M | 10.5% | 740,918 SH | New |
| PLAINS GP HLDGS L P | LTD PARTNR INT A | $24.4M | 20.8% | 1,272,360 SH | New |
| REGENXBIO INC | COM | $1.7M | 1.4% | 116,896 SH | New |
| SAB BIOTHERAPEUTICS INC | COM NEW | $2.4M | 2.1% | 652,881 SH | New |
| VIRIDIAN THERAPEUTICS INC | COM | $8.8M | 7.5%Prev: 1.9% | 282,531 SH | Increased+192,531 SH |
| ZEVRA THERAPEUTICS INC | COM NEW | $571K | 0.5%Prev: 2.2% | 63,683 SH | Decreased-168,191 SH |
| 13F-HR |
| 0001829126-26-008753 |
| $191.1M |
| View |
| Aug 13, 2025 | Q2 2025 | 13F-HR | 0000898432-25-000591 | $82.4M | View |
| May 14, 2026 | Q1 2026 | 13F-HR | 0000898432-26-000369 | $158.7M | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0000898432-25-000357 | $86.1M | View |